国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2009年
6期
68-69
,共2页
单唾液神经节苷脂%奥扎格雷钠%脑梗死%疗效
單唾液神經節苷脂%奧扎格雷鈉%腦梗死%療效
단타액신경절감지%오찰격뢰납%뇌경사%료효
Monosialotetrahexosylganglioside%Ozagred%Cerebral infarction%Carative effect
目的 观察单唾液神经节苷脂(GM1)联合奥扎格雷钠治疗急性脑梗死的疗效.方法 将80例发病72 h内的急性脑梗死患者,随机分为两组,对照组采用奥扎格雷钠治疗,治疗组在对照组基础上加用神经节苷脂(GM1),治疗1个疗程后(14日)采用中国卒中程度评分(CSS),Barthel指数评价神经功能恢复状况.结果 治疗组显效率为57.5%,有效率为25%,对照组显效率为30%,有效率为45%,两组比较,差异无显著性意义.治疗组Barhel指数变化较对照组明显,两组比较,P＜0.05.无不良反应发生.结论 神经节苷脂(GM1)联合奥扎格雷钠能提高急性脑梗死病人的临床治疗效果.
目的 觀察單唾液神經節苷脂(GM1)聯閤奧扎格雷鈉治療急性腦梗死的療效.方法 將80例髮病72 h內的急性腦梗死患者,隨機分為兩組,對照組採用奧扎格雷鈉治療,治療組在對照組基礎上加用神經節苷脂(GM1),治療1箇療程後(14日)採用中國卒中程度評分(CSS),Barthel指數評價神經功能恢複狀況.結果 治療組顯效率為57.5%,有效率為25%,對照組顯效率為30%,有效率為45%,兩組比較,差異無顯著性意義.治療組Barhel指數變化較對照組明顯,兩組比較,P＜0.05.無不良反應髮生.結論 神經節苷脂(GM1)聯閤奧扎格雷鈉能提高急性腦梗死病人的臨床治療效果.
목적 관찰단타액신경절감지(GM1)연합오찰격뢰납치료급성뇌경사적료효.방법 장80례발병72 h내적급성뇌경사환자,수궤분위량조,대조조채용오찰격뢰납치료,치료조재대조조기출상가용신경절감지(GM1),치료1개료정후(14일)채용중국졸중정도평분(CSS),Barthel지수평개신경공능회복상황.결과 치료조현효솔위57.5%,유효솔위25%,대조조현효솔위30%,유효솔위45%,량조비교,차이무현저성의의.치료조Barhel지수변화교대조조명현,량조비교,P＜0.05.무불량반응발생.결론 신경절감지(GM1)연합오찰격뢰납능제고급성뇌경사병인적림상치료효과.
Objective To observe the effect of gliosidle ( GM1 ) combines with ozagrel therapy the Acute Cerebral Infarction .Methods 80 patients from the onset within 72 h were randomly divided into two groups.The treatment group were treated with GM1 combines with ozagrel ,the control group were treateal with ozagrel.To observe the curative effect of after a peride of treatment (fourteen days ).The Chinese Stroke Scale (CSS),Barthel lndex(Bl) were used to evaluatd the recovery of neurological funitions.Resuits The obvious effective rate of the therapy was 57.5% response rate was 25%, whereas, these date of the control group were 30% and 45% ; respectively.The Barthel Index significantly changed in treatment group( P<0.05 ).Conclusion It's effect on therapy the acute cerebral infarction was better in the therapy group than in the control group.
